Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by coyote13on Apr 03, 2016 10:11pm
248 Views
Post# 24726250

RE:CC Highlights

RE:CC HighlightsBob: appreciate the work you did to compile the list of "nuggets"f rom the CC. I need to listen to the call to get the "colour" version. 

If PL can execute as you have outlined, 2016 will be a year to remember.

I continue to believe the market will not reward PLI with a proper valuation  until PL can produce concrete evidence( ie 3rd party transactions) of the true worth  our products. The analysts targets are ultra conservative with the exception of Beacon and won't, by themselves,  take us higher. They are nice to have but are not what the buy side  money is relying on. 

Until the geographic rights to some of the pieces are sold off assuming those values are reflective of PL's optimism or the path to commercialization becomes crystal clear, our daily valuation will be susceptible to the games of the market.

When it happens, the revaluation of our market cap could be truly stunning.

Until then, we wait.

Coyote13



 


Bullboard Posts